RecruitingNCT06680817

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Real-World, Long-Term Data Collection to Gain Clinical Insights Into Faricimab (FaReal Study)

Sponsor

Hoffmann-La Roche

Enrollment

850 participants

Start Date

Feb 5, 2025

Study Type

OBSERVATIONAL

Conditions

Neovascular Age-related Macular Degeneration Diabetic Macular Edema

Summary

The FaReal study aims to evaluate the effectiveness, safety, clinical insights and treatment patterns in patients treated with faricimab, in neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) in at least one eye, in real-world routine clinical practice over a 2-year patient follow-up period. Additionally, the FaReal study also aims to describe and evaluate health economic aspects of previous anti-VEGF treatments and current treatment with faricimab.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Faricimab for people with diabetic macular edema and neovascular age-related macular degeneration. The study is currently recruiting participants at 59 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFaricimab

Faricimab will be administered as per local clinical practice and local labeling.

Locations(59)

LKH-Univ.Klinikum Graz

Graz, Austria

Medizinische Universität Innsbruck

Innsbruck, Austria

Kepler Universitätskliniken GmbH - Med Campus III

Linz, Austria

Medizinische Universitat Wien

Vienna, Austria

Hanusch Krankenhaus

Vienna, Austria

Multiprofile Hospital for Active Treatment Trimontium OOD Plovdiv;Ophthalmology

Plovdiv, Bulgaria

Eye Medical Center St. Luka

Plovdiv, Bulgaria

Eye Diseases Medical Center LUX OPTICS;ophthalmology

Sofia, Bulgaria

Tokuda Hospital

Sofia, Bulgaria

Medical Clinic Svetlina

Sofia, Bulgaria

Ambulatory for Group Practice for Specialized Medical Care in Ophthalmology - Dr. Grupchevi OOD;Ophthalmology

Varna, Bulgaria

Krajska nemocnice Liberec a.s.

Liberec, Czechia

Klaudianova Nemocnice - Mlada Boleslav;Ophtalmology dpt

Mladá Boleslav, Czechia

Fakultni nemocnice Olomouc

Olomouc, Czechia

Faculty Hospital Ostrava

Ostrava, Czechia

Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha

Prague, Czechia

Helsinki University Central Hospital

Helsinki, Finland

Tampere University Hospital

Tampere, Finland

General Hospital of Athens "Korgialeneio - Benakeio" Hellenic Red Cross

Athens, Greece

University General Hospital of Heraklion

Heraklion, Greece

University Hospital of Larissa

Larissa, Greece

Papageorgiou General Hospital of Thessaloniki

Thessaloniki, Greece

Erzsebet Furdo Gyogyaszati es Szurokozpont

Miskolc, Hungary

Pecsi Tudomanyegyetem Klinikai Kozpont

Pécs, Hungary

Szegedi Tudományegyetem ÁOK

Szeged, Hungary

Mater Private Hospital

Dublin, Ireland

Bon Secours Hospital, Limerick

Limerick, Ireland

Institute of Eye Surgery

Waterford, Ireland

Barzilai Medical Center

Ashkelon, Israel

Shamir Medical Center Assaf Harofeh

Beer Jacob, Israel

Soroka university medical center

Beersheba, Israel

Carmel medical center

Haifa, Israel

Shaare Zedek Medical Center

Jerusalem, Israel

Pauls Stradins Clinical University hospital

Riga, Latvia

Riga East Clinical University hospital Bikernieki

Riga, Latvia

Latvian-American Eye Center

Riga, Latvia

Jeroen Bosch Ziekenhuis

's-Hertogenbosch, Netherlands

ETZ Elisabeth

Tilburg, Netherlands

NZOZ Specjalistyczna Poradnia Lekarska Adrian Wojciech Przystupa

Bielsk Podlaski, Poland

Centrum Uslug Medycznych OKO-MED

Grudziądz, Poland

USK Nr 2 im. WAM w Lodzi, Centralny Szpital Weteranow

Lodz, Poland

Szpital Wojewodzki w Poznaniu

Poznan, Poland

Pomorski Uniwersytet Medyczny

Szczecin, Poland

Szpitale Pomorskie, Szpital Specjalistyczny im. F. Ceynowy

Wejherowo, Poland

Szpital Uniwersytecki im. Karola Marcinkowskiego w Zielonej Górze

Zielona Góra, Poland

Espaco Medico Coimbra

Coimbra, Portugal

ULS Lisboa Ocidental - Hospital Egas Moniz

Lisbon, Portugal

Hospital CUF Tejo

Lisbon, Portugal

IMO - Instituto de Microcirurgia Ocular

Lisbon, Portugal

Hospital de Sao Joao

Porto, Portugal

Retina Clinic

Bucharest, Romania

Clinica Bine

Bucharest, Romania

Vista Vision

Bucurescti, Romania

Centrul Oftalmologic Dr. Munteanu

Timișoara, Romania

Nemocnica s poliklinikou Trebišov, a.s.

Trebišov, Slovakia

Fakultna nemocnica Trencin Ocna klinika

Trenčín, Slovakia

Fakultna nemocnica Trnava

Trnava, Slovakia

OFTAL s.r.o. Specializovana nemocnica v odbore oftalmologia Zvolen

Zvolen, Slovakia

General Hospital Murska Sobota

Murska Sobota, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06680817

Related Trials

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

NCT0742552210 locations

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

NCT0761477629 locations

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

NCT07007065129 locations

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

NCT0755342930 locations

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

NCT0485325152 locations